louisiana glp-1 gi obstruction class action Ozempic Lawsuit [2026 Update] glp-1 gi obstruction lawsuit in

All it takes is the a few injections to hit your goal weight

Get the most from these pricey new obesity drugs by choosing the right coverage strategy and helping your members build lifelong habits.

Hanmi expects to initiate Phase 1 clinical trials for HM17321 in the second half of 2025.According to recent reports from GlobalData Patent Analytics and IFI CLAIMS Patent Services, Hanmi ranks among the global leaders in both the volume and quality of obesity drug patent filings, alongside multinational pharmaceutical companies such as Eli Lilly and Novo Nordisk.Innovation in metabolic and endocrine diseases has been a core focus for Hanmi over many years, and the ADA 2025 presentations represent a critical opportunity to showcase our global competitiveness, said Dr

These ingredients have been studied for their ability to help support glucose metabolism, support digestion, and maintain a healthy inflammatory response

Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.